Novo stock falls 7% despite $23 billion sales target for blockbuster obesity drugs
- Posted on September 21, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
Novo stock falls 7% despite $23 billion sales target for blockbuster obesity drugs
Novo stock falls 7% despite $23 billion sales target for blockbuster obesity drugs continue reading...